Media coverage
1
Media coverage
Title PharmaEssentia Initiates Phase 3b Trial of Ropeginterferon alfa-2b-njft Investigatng New Dosing Regimen for Patients With Polycythemia Vera (PV) Media name/outlet South Africa - Knowledia News Country/Territory South Africa Date 3/05/23 URL https://news.knowledia.com/ZA/en/articles/pharmaessentia-initiates-phase-3b-trial-of-ropeginterferon-alfa-2b-njft-dd4db9a68ae8d3b9b1b05767d2edf8ec7abf94a9?source=rss Persons John Mascarenhas